A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.

Komsomolskaya Pravda newspaper compiled a social responsibility ranking of Russian billionaires and the corporations they lead. Vladimir Potanin is ranked at the top with a wide margin from everyone who actively joined the fight against the epidemic.

Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.

Vladimir Potanin spoke at the celebration marking the 20th anniversary of his Foundation. He outlined his vision for the future of the Foundation and explained what parameters he uses to evaluate its work. He believes that charitable work has to take into account feedback: social needs and demands.